植物由来のバイオ医薬品:臨床導入を推進する技術開発の事例
George P Lomonossoff1, Marc-André D'Aoust2
1Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK. george.lomonossoff@jic.ac.uk.
まとめ
薬用タンパク質の生産のためのバイオリアクターとして開発されています. 最近の技術的な進歩は,特に臨床試験での応用について,新たな関心をもたらしています.
科学分野:
- 植物バイオテクノロジー
- 分子農業
- バイオ医薬品の生産
背景:
- 複雑な薬剤タンパク質を生産するための 拡張性があり費用対効果の高いプラットフォームを 植物が提供しています
- 初期の取り組みは 商業化と臨床翻訳の課題に直面しました
- 最近の技術的進歩により,植物ベースのバイオマニュファクチャリングへの関心が復活しました.
研究 の 目的:
- 植物性製薬用タンパク質の生産における技術的進歩を見直す.
- 臨床用途のバイオリアクターとしての現在の景観と将来の可能性を評価する.
主な方法:
- 科学出版物と特許の文献レビュー
- 植物発現システムの技術的発展の分析
- 臨床試験に関連するケーススタディの検討
主要な成果:
- タンパク質の生産量と品質と ダウンストリーム処理の 重要な改善
- 遺伝子工学と 植物の栽培技術の進歩
- 臨床前および臨床開発に参入する植物由来生物学的薬の数は増加しています.
結論:
- 植物ベースのシステムは バイオ医薬品の製造にますます有効です
- 継続的なイノベーションにより,臨床導入の残った障害を克服することが期待されています.
- 低価格で入手可能な薬の将来に 植物には大きな希望があります
関連する概念動画
Recombinant DNA
104.5K
Overview
104.5K
Plant Breeding and Biotechnology
22.1K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
22.1K
Drug Products: Biologics, Biosimilars and Interchangeables
336
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
336
Transgenic Plants
9.0K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
9.0K
Hybridoma Technology
18.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
18.2K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
307
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
307


